SecProbe.io

CORRESP
1
filename1.htm

December
12, 2018

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Chardan Healthcare Acquisition Corp. (the
    “Company”)

    Registration Statement on Form S-1

    File No. 333-228533

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Chardan Capital Markets LLC, as representative
of the underwriters, hereby joins the request of the Company that the effective date of the above-referenced Registration Statement
on Form S-1 be declared effective at 4:00 p.m. (Washington, D.C. time) on December 13, 2018, or as soon as practicable thereafter.

The
following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

    (i)
    Date of preliminary prospectus: December 7,
    2018.

    (ii)
    Dates of distribution: December 7, 2018 through
    the date hereof.

    (iii)
    Number of prospective underwriters and selected
    dealers to whom the preliminary prospectus was furnished: 14 (other than Chardan Capital Markets LLC).

    (iv)
    Number of prospectuses so distributed: 267.

The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed
by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange
Act of 1934, as amended, in connection with the above-referenced issue.

    Sincerely,

    Chardan Capital Markets LLC

    By:
     /s/
    George Kaufman

    Name:
     George Kaufman

    Title:
     Managing Director